In the initial ovarian tumor, biallelic BRCA2 inactivation was present, with the known germline p.W563*BRCA2 mutation and a second somatic frameshift p.K650fs*8 deletion detected at an allele frequency of 16.4% (105/639 reads). This evidence concerns the gene BRCA2 and ovarian neoplasm.